My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


OpenAI, Anthropic, SpaceX IPOs Could End Big...
Adobe Pauses Price Hikes For 'Short-Term' AI...
Trump Says Iran 'Better Get Their Act Togethe...
GameStop Didn't Make Money With Its Bitcoin B...
Value Investors Question SpaceX's Record IPO:...
Google Sounds Alarm On Active Oracle PeopleSo...
Chinese Customers Can Now Order NVIDIA's Vera...
SpaceX's IPO Could Spark A Venture Capital Fr...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ: BNTX)

    Overview
    current price
    $90.54
    $90.54
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    90.54
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    1.04 M
    1 day
    0.00 - 0.00
    52 weeks
    79.52 - 124.00
    p/e
    0.00
    beta
    1.3029
    market cap
    22.90 B
    dividend yield
    0.00%
    Industry
    -
    BNTX by TradingView
    News and Commentary
    Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot BioNTech SE (BNTX
    Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax Moderna Inc. (MRNA&nbs...
    Pfizer, BioNTech Roll Out COVID-19 Update That Boosts Antibodies 4-Fold In High-Risk Adults Pfizer Inc. (PFE 
    FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.'s
    Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety S... The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s
    Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps Novavax, Inc. (NVAX&nb...
    Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows Moderna Inc. (MRNA&nbs...
    UK, Taiwan Approve Moderna's Updated COVID-19 Shot On Tuesday, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved Moderna, Inc.'s
    Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program Starting in late September, U.S. households can order up to four COVID-19 nasal swab tests when the federal program reopens.The exact date for ordering...
    FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to...
    StockTwits
    StockTwits
    Most Shared
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Best Buy Stock Pops After Strong Comparable Sales, Margin Growth
    US Says China To Buy At Least $17 Billion Worth Agricultural Goods Annually After Trump-Xi Meet
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    The AI Spending Boom Just Got Bigger: Goldman Sees $800 Billion Flowing In This Year
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?